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PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY AND STENTING OF
EXTRACRANIAL VERTEBRAL ARTERY STENOSES
Isabelle P henry1, Amira Benjelloun2, Michel C. Henry3
1Polyclinique Bois Bernard, BOIS BERNARD, France, 2Clinique Coeur et Vaisseaux,
RABAT, Morocco, 3Cabinet de cardiologie, nancy, France
Background: To evaluate the safety and efﬁciency of vertebral angioplasty and
stenting (VAS) in symptomatic patients.
Methods: 102 angioplasties in 96 pts (M:72) mean age 68,3  6,7 years (22-84) left
58. All pts had multivascular diseases: carotid (CA):63, subclavian (SA): 26, coro-
nary:64.. Atheromatous lesions: 100, inﬂammatory: 2. Mean lesion length: 9,6 +/-
2,8 mm. Mean % stenosis 83.2  7.7, mean arterial diameter : 4,8  0,6 mm (4-6). 94
lesions at VO segment (ostium), 6 at V1 and 2 at V2 segments. Indications for
angioplasty: dizziness (96), bilateral weakness (11), visual changes (11), diplopia (10),
drop attacks (20), TIA (13), ataxia (5). A protection device (ﬁlter) used in 10 pts. 20
SA angioplasties performed at the same time of VAS, 8 CA. All angioplasties per-
formed by femoral approach, 4 by brachial approaches after failure of femoral
approach. (2 successes).
Results: Technical success 100/102 (98%). 6 lesions treated by angioplasty alone: 3
VO (ﬁrst 3 pts. 2 V1, 1 V2 lesion). 1 pt (inﬂammatory disease) treated by cutting
balloon alone. 93 lesions treated with stents (direct stenting: 78). Peripheral balloon
expandable stents (n¼23), self expandable stents (n¼4 for 3 V1 and one V2 lesions).
70 coronary stents (14 DES). 1 pt developed a TIA during the procedure. No
neurological complications at 30 days Clinical success 94/96 (98%) Post-procedure
arterial diameter: 4,55  0,8 mm (4-6). Mean residual stenosis 2,2  3,5 %. In 10 pts
treated with protection devices, visible debris removed in 7 (5 Filterwire, 2 Fibernet)
with the same amount of debris as during Carotid Stenting) 7 pts (8%) developed
a symptomatic restenosis during the follow-up (mean: 31.4.28.9 months), 3 after
PTA alone, 4 after PTA and stent (1 occlusion treated medically, 6 stenoses
successfully treated with PTA). No restenosis after DES implantation at 1 year.
Conclusions: VAS can be performed safely and effectively with a high technical
success rate, a low complication rate, a low restenosis rate and a durable clinical
success in patients with symptomatic VA stenosis. Stents seem to improve immediate
and long-term results. The role of protection devices and D.E.S has to be discussed
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Carotid Stenting Versus Endarterectomy:10 Year Randomized Trial
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Background:Modern clinical trials with short-term follow-up indicate CAS and CEA
are equivalent in reducing the risk for ipsilateral ischemic stroke secondary to carotid
stenosis. A paucity of data exists regarding long term outcomes.
Methods: Patients with symptomatic and asymptomatic of all surgical risks with
carotid stenosis (>70%) were randomly selected for CEA or CAS and followed
a minimum of ten years.
Results: Long-term follow up was achieved in 173 patients (91%). Eighty-seven
(50.2%) died within this period, most commonly of non-vascular causes. No differ-
ences in occurrence and/or risk of stroke ipsilateral to the treated artery was noted
among treatment groups (p¼0.61). Restenosis determined by sequential ultrasound
was seen only in the CAS group (3.3%) and remained asymptomatic. The combined
risk of fatal or non-fatal heart attack was highest in individuals with symptomatic
compared to asymptomatic stenosis. (27.5% vs. 11.0%; p¼<0.05)) and was higher in
all patients treated with CEA (p¼0.02).
Conclusions: Long-term protection against ipsilateral stroke provided by CAS and
CEA is equivalent. The 10 year risk of fatal/non-fatal myocardial infarction is highest
in all patients harboring symptomatic carotid stenosis at enrollment however the risks
of fatal/non-fatal heart attack are much more prevalent in all patients, symptomatic and
asymptomatic, randomized to CEA.JACC Vol 62/18/Suppl B j October 27–November 1, 2013 j TCT AbstrTCT-503
The Challenge of Left Internal Carotid Stenosis Stenting and Bovine Aortic Arch
(BAAC):Systematic Right Radial or Brachial Approach in 60 Consecutive
Patients
piero montorsi1, Stefano Galli1, Paolo M. Ravagnani1, Daniela Trabattoni1,
Giovanni Ballerini1, Franco Fabbiocchi1, Alessandro Lualdi1, Daniele Andreini1,
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Background: BAAC refers either to left common carotid artery (LCCA) origin from
the innominate artery (type 2) or from a common origin from the aorta (type
1).When left internal carotid artery(LICA)stenosis is present,CAS from the femoral
approach may be difﬁcult, increasing the risk of technical failure and cerebral
embolization.
Methods: Between 2007 and 2012, 60/505 (11.8%) consecutive pts with LICA
stenosis and BAAC underwent CAS with cerebral protection from right radial or
brachial approach. Type of cerebral protection (distal vs. proximal), stent (open vs.
closed cell design) and technique (direct stenting vs. predilation) were left at oper-
ation's discretion. Double antiplatelet treatment was maintained up to 3 months after
CAS. Procedural variables such as ﬂuoroscopy time, radiation exposure, contrast
medium and technical failure were compared to that of a comparable group of 13 pts
with BAAC undergoing CAS by femoral catheterization.
Results: Type 2 BAAC was present in 86% of pts. The mean age was 739 years
(>75 years, 45%).Male gender was 73%,75% had high-surgical-risk characteristics
and 83% were asymptomatic. Radial or brachial approach was used in 54% and 46%
of pts, respectively. Technical success was 98.3% (1 pt crossed over to femoral
approach). Clinical success was 96.7% (1 retinal embolism and 1 minor stroke).
Proximal protection (8FMO.MA) was used in 15 cases (11 brachial,4 radial) with 1
device failure (shift to ﬁlter) and 100% procedural and 100% clinical successes.
Vascular complications occurred in 2/0 pts in the brachial/radial group, respectively.
No major bleeding occurred. Fluoroscopy time (p<0.05),contrast medium (p<0.03),
radiation exposure (p¼0.08) and technical failure (1.6% vs. 16.6%,p¼0.06) were
reduced as compared to femoral catheterization.
Conclusions: CAS through right radial or brachial approach is safe and effective in
pts with LICA stenosis and BAAC. Advantages over femoral approach include:
avoidance of aortic arch, favorable anatomic pathway for LCCA cannulation, choice
between two arterial accesses, use of proximal protection, low bleeding and vascular
complication rates (especially from the radial approach) and early patients'
ambulation.TCT-504
Randomized comparison of transradial and transfemoral approach for carotid
artery stenting
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Background: Limited data exist on radial access in carotid artery stenting (CAS).
This multicenter prospective randomized study was performed to compare the
outcome and complication rate of transradial (TR) and transfemoral (TF) CAS.
Methods: The clinical and angiographic data of 260 consecutive patients high risk for
carotid endarterectomy (CEA) treated by CAS with cerebral protection between 2010
and 2012 were evaluated. Patients were randomized to TR (n ¼130) or TF (n ¼130)
groups and several parameters were evaluated: Primary endpoint: MACCE, rate of
access site complications. Secondary endpoint: angiographic outcome of the CAS,
ﬂuoroscopy time and X Ray dose, procedural time, cross over rate to another puncture
site and hospitalisation in days.
Results: Procedural success was achieved in 260 patients (100%), the cross over rate
was 10 % in the TR and 1.5% in the TF group (p<0.05). Major access site compli-
cation was encountered in 1 patient (0.9%) in the TR and in 1 patient (0.8%) in the TF
group (p¼ns). The incidence of MACCE was 0.9% in the TR and 0.8% in the TF
group (p¼ns). Procedure time (1744742 vs. 1665744 sec, p¼ns) and ﬂuoroscopy
time (613289 vs. 579285 sec, p¼ns) was not signiﬁcantly different, but the
radiation dose was signiﬁcantly higher in the TR group (223138 vs.
182106Gycm2, p<0.05).
Conclusions: The transradial approach for carotide artery stenting has the same
efﬁcacy and safety as transfemoral, however the cross over rate and radiation dose is
higher and hospitalisation is shorter with transradial access.acts/POSTER/Carotid and Neurovascular Intervention B153
